Screener
Medline, Inc. MDLN Income taxes at U.S. statutory rate of 21%
Income taxes at U.S. statutory rate of 21% at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.
The source filing: Medline, Inc.’s 10-K, filed February 25, 2026.
- Filed
- Feb 25, 2026, 4:51 PM EST
- Fiscal year
- FY2025
- Accession
- 0002046386-26-000009
| (in millions) | Year ended / December 31, 2025 | Year ended / December 31, 2025 | Year ended / December 31, 2025 |
|---|---|---|---|
| Income tax expense at U.S. statutory rate | $ | $262 | 21.0% |
| State and local tax effect, net of federal benefit (1) | 4 | 0.4% | |
| Statutory income tax rate differential (2) | (19) | (1.5)% | |
| Effects of changes in tax laws or rates enacted in the current period | 2 | 0.1% | |
| Effects of cross-border tax laws (3) | 2 | 0.2% | |
| Changes in valuation allowance | (1) | (0.1)% | |
| Nontaxable or non deductible items | |||
| Impact of non-taxable partnership earnings | (160) | (12.8)% |
Item 8 - Financial Statements and Supplementary Data
FAQ
- What is Medline, Inc.'s income taxes at U.S. statutory rate of 21%?
- Medline, Inc. (MDLN) reported income taxes at U.S. statutory rate of 21% of $0.05 in Q4 2025.
- What does income taxes at U.S. statutory rate of 21% mean?
- Income taxes at U.S. statutory rate of 21%
Ask your AI about Medline, Inc.'s income taxes at u.s. statutory rate of 21%.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude